| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
Submitted on August 31, 2005
Accepted on January 20, 2006
University Department of Growth and Reproduction (T.H.J., K.M.M.), Rigshospitalet, DK-2100 Copenhagen, Denmark; Department of Health Psychology (C.P.L.R, E.L.M.), Institute of Public Health, University of Copenhagen, Denmark; The Kinsey Institute for Research in Sex, Gender, and Reproduction (J.M.R.), Indiana University, Bloomington, IN 47405, USA, University Department of Clinical Genetics (M.S.), Rigshospitalet, DK-2100 Copenhagen, Denmark
* To whom correspondence should be addressed. E-mail: trinejohannsen{at}rh.dk.
Context: Congenital adrenal hyperplasia (CAH) is a disorder with a wide spectrum of severity.
Objective: To investigate cognitive function in CAH women.
Design: A case-control study.
Setting: A tertiary center for pediatric endocrinology at the University Hospital of Copenhagen.
Participants: Thirty-five Danish CAH women (age 17-51 yr) were included, participation rate 84%. Control women were recruited through the Danish Civil Registration System and matched on age and education.
Main Outcome Measures: An abbreviated form of the Wechsler Adult Intelligence Scale, i.e. full scale IQ (5 of 11 subtests), which included 3 of 6 verbal IQ subtests and 2 of 5 performance IQ subtests.
Results: A significantly lower IQ was found in CAH patients compared with controls with respect to mean full scale IQ (84.5 vs. 99.1; P < 0.001), mean verbal IQ (86.6 vs. 97.3; P < 0.001), and mean performance IQ (85.7 vs. 101.3; P < 0.001). The salt-wasting CAH group had lower IQ-scores than the simple-virilizing CAH group, which reached significance for mean total IQ (81.2 vs. 92.8, P = 0.04) and mean verbal IQ (84.7 vs. 95.5, P = 0.05), and additionally, lower scores than the late-onset CAH group, which reached significance for performance IQ (mean 81.5 vs. 96.2, P = 0.02).
Conclusions: Impaired cognitive function was observed in patients with CAH, especially in salt-wasting CAH. These intriguing findings may reflect adverse effects of hyponatremic episodes, sub-optimal postnatal hormone replacement therapy or prenatal adrenal androgen excess, as well as the potential psychosocial consequences of the disorder.
This article has been cited by other articles:
![]() |
O. Inozemtseva, E. Matute, and J. Juarez Learning Disabilities Spectrum and Sexual Dimorphic Abilities in Girls with Congenital Adrenal Hyperplasia J Child Neurol, August 1, 2008; 23(8): 862 - 869. [Abstract] [PDF] |
||||
![]() |
D. P. Merke Approach to the Adult with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 653 - 660. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. H Johannsen, C. P L Ripa, E. L Mortensen, and K. M Main Quality of life in 70 women with disorders of sex development Eur. J. Endocrinol., December 1, 2006; 155(6): 877 - 885. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |